Drugs / Meganatural-Az Grapeseed Extract
last change Oct 2019 re-read 3 minutes ago

Meganatural-Az Grapeseed Extract

Developed for
Alzheimer disease

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 2 NCT02033941 Comparator Jul 2018 → Oct 2019 Alzheimer disease Hillel Grossman Terminated No outcome recorded Stop: Enrollment

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Meganatural-Az Grapeseed Extract ClinicalTrials.gov intervention name — accepted as the source's own label NCT02033941 ↗